This symposium summary, sponsored by the ASPET, was held at Experimental Biology 2015 on March 29, 2015, in Boston, Massachusetts. The symposium focused on: 1) the interactions of cytochrome P450s (P450s) with their redox partners; and 2) the role of the lipid membrane in their orientation and stabilization. Two presentations discussed the interactions of P450s with NADPH-P450 reductase (CPR) and cytochrome b5. First, solution nuclear magnetic resonance was used to compare the protein interactions that facilitated either the hydroxylase or lyase activities of CYP17A1. The lyase interaction was stimulated by the presence of b5 and 17α-hydroxypregnenolone, whereas the hydroxylase reaction was predominant in the absence of b5. The role of b5 was also shown in vivo by selective hepatic knockout of b5 from mice expressing CYP3A4 and CYP2D6; the lack of b5 caused a decrease in the clearance of several substrates. The role of the membrane on P450 orientation was examined using computational methods, showing that the proximal region of the P450 molecule faced the aqueous phase. The distal region, containing the substrate-access channel, was associated with the membrane. The interaction of NADPH-P450 reductase (CPR) with the membrane was also described, showing the ability of CPR to "helicopter" above the membrane. Finally, the endoplasmic reticulum (ER) was shown to be heterogeneous, having ordered membrane regions containing cholesterol and more disordered regions. Interestingly, two closely related P450s, CYP1A1 and CYP1A2, resided in different regions of the ER. The structural characteristics of their localization were examined. These studies emphasize the importance of P450 protein organization to their function.

Departments of Medicinal Chemistry and Pharmaceutical Chemistry The University of Kansas Lawrence Kansas

Zobrazit více v PubMed

Ahmed SN, Brown DA, London E. (1997) On the origin of sphingolipid/cholesterol-rich detergent-insoluble cell membranes: physiological concentrations of cholesterol and sphingolipid induce formation of a detergent-insoluble, liquid-ordered lipid phase in model membranes. Biochemistry 36:10944–10953. PubMed

Akhtar MK, Kelly SL, Kaderbhai MA. (2005) Cytochrome b(5) modulation of 17alpha hydroxylase and 17-20 lyase (CYP17) activities in steroidogenesis. J Endocrinol 187:267–274. PubMed

Anzenbacher P, Anzenbacherová E. (2001) Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 58:737–747. PubMed PMC

Auchus RJ, Lee TC, Miller WL. (1998) Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J Biol Chem 273:3158–3165. PubMed

Balaz S. (2009) Modeling kinetics of subcellular disposition of chemicals. Chem Rev 109:1793–1899. PubMed PMC

Balvers WG, Boersma MG, Vervoort J, Ouwehand A, Rietjens IM. (1993) A specific interaction between NADPH-cytochrome reductase and phosphatidylserine and phosphatidylinositol. Eur J Biochem 218:1021–1029. PubMed

Baylon JL, Lenov IL, Sligar SG, Tajkhorshid E. (2013) Characterizing the membrane-bound state of cytochrome P450 3A4: structure, depth of insertion, and orientation. J Am Chem Soc 135:8542–8551. PubMed PMC

Berka K, Hendrychová T, Anzenbacher P, Otyepka M. (2011) Membrane position of ibuprofen agrees with suggested access path entrance to cytochrome P450 2C9 active site. J Phys Chem A 115:11248–11255. PubMed PMC

Berka K, Paloncýová M, Anzenbacher P, Otyepka M. (2013) Behavior of human cytochromes P450 on lipid membranes. J Phys Chem B 117:11556–11564. PubMed

Berkowitz ML. (2009) Detailed molecular dynamics simulations of model biological membranes containing cholesterol. Biochim Biophys Acta 1788:86–96. PubMed

Black SD. (1992) Membrane topology of the mammalian P450 cytochromes. FASEB J 6:680–685. PubMed

Black SD, Coon MJ. (1982) Structural features of liver microsomal NADPH-cytochrome P-450 reductase: hydrophobic domain, hydrophilic domain, and connecting region. J Biol Chem 257:5929–5938. PubMed

Bridges A, Gruenke L, Chang YT, Vakser IA, Loew G, Waskell L. (1998) Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase. J Biol Chem 273:17036–17049. PubMed

Brignac-Huber L, Reed JR, Backes WL. (2011) Organization of NADPH-cytochrome P450 reductase and CYP1A2 in the endoplasmic reticulum--microdomain localization affects monooxygenase function. Mol Pharmacol 79:549–557. PubMed PMC

Brignac-Huber LM, Reed JR, Eyer MK, Backes WL. (2013) Relationship between CYP1A2 localization and lipid microdomain formation as a function of lipid composition. Drug Metab Dispos 41:1896–1905. PubMed PMC

Browman DT, Resek ME, Zajchowski LD, Robbins SM. (2006) Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER. J Cell Sci 119:3149–3160. PubMed

Brown DA, London E. (2000) Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275:17221–17224. PubMed

Causey KM, Eyer CS, Backes WL. (1990) Dual role of phospholipid in the reconstitution of cytochrome P-450 LM2-dependent activities. Mol Pharmacol 38:134–142. PubMed

Cojocaru V, Balali-Mood K, Sansom MSP, Wade RC. (2011) Structure and dynamics of the membrane-bound cytochrome P450 2C9. PLOS Comput Biol 7:e1002152. PubMed PMC

Cojocaru V, Winn PJ, Wade RC. (2007) The ins and outs of cytochrome P450s. Biochim Biophys Acta 1770:390–401. PubMed

Davydov DR. (2011) Microsomal monooxygenase as a multienzyme system: the role of P450-P450 interactions. Expert Opin Drug Metab Toxicol 7:543–558. PubMed PMC

Davydov DR, Davydova NY, Sineva EV, Halpert JR, Halpert JR. (2015) Interactions among cytochromes P450 in microsomal membranes: oligomerization of cytochromes P450 3A4, 3A5, and 2E1 and its functional consequences. J Biol Chem 290:3850–3864. PubMed PMC

Davydov DR, Sineva EV, Sistla S, Davydova NY, Frank DJ, Sligar SG, Halpert JR. (2010) Electron transfer in the complex of membrane-bound human cytochrome P450 3A4 with the flavin domain of P450BM-3: the effect of oligomerization of the heme protein and intermittent modulation of the spin equilibrium. Biochim Biophys Acta 1797:378–390. PubMed PMC

Denisov IG, Shih AY, Sligar SG. (2012) Structural differences between soluble and membrane bound cytochrome P450s. J Inorg Biochem 108:150–158. PubMed PMC

Denisov IG, Sligar SG. (2011) Cytochromes P450 in nanodiscs. Biochim Biophys Acta 1814:223–229. PubMed PMC

Endo S, Escher BI, Goss KU. (2011) Capacities of membrane lipids to accumulate neutral organic chemicals. Environ Sci Technol 45:5912–5921. PubMed

Estrada DF, Laurence JS, Scott EE. (2013) Substrate-modulated cytochrome P450 17A1 and cytochrome b5 interactions revealed by NMR. J Biol Chem 288:17008–17018. PubMed PMC

Estrada DF, Laurence JS, Scott EE. (2016) Cytochrome P450 17A1 interactions with the FMN domain of its reductase as characterized by NMR. J Biol ChemDOI: 291:3990–4003. PubMed PMC

Estrada DF, Skinner AL, Laurence JS, Scott EE. (2014) Human cytochrome P450 17A1 conformational selection: modulation by ligand and cytochrome b5. J Biol Chem 289:14310–14320. PubMed PMC

Evans WE, Relling MV. (1999) Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286:487–491. PubMed

Finn RD, McLaughlin LA, Hughes C, Song C, Henderson CJ, Roland Wolf C. (2011) Cytochrome b5 null mouse: a new model for studying inherited skin disorders and the role of unsaturated fatty acids in normal homeostasis. Transgenic Res 20:491–502. PubMed PMC

Finn RD, McLaughlin LA, Ronseaux S, Rosewell I, Houston JB, Henderson CJ, Wolf CR. (2008) Defining the in Vivo Role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5. J Biol Chem 283:31385–31393. PubMed PMC

Geller DH, Auchus RJ, Miller WL. (1999) P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5. Mol Endocrinol 13:167–175. PubMed

Ghosh MC, Ray AK. (2013) Membrane phospholipid augments cytochrome P4501a enzymatic activity by modulating structural conformation during detoxification of xenobiotics. PLoS One 8:e57919. PubMed PMC

Guengerich FP. (2006) Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J 8:E101–E111. PubMed PMC

Hasegawa M, Kapelyukh Y, Tahara H, Seibler J, Rode A, Krueger S, Lee DN, Wolf CR, Scheer N. (2011) Quantitative prediction of human pregnane X receptor and cytochrome P450 3A4 mediated drug-drug interaction in a novel multiple humanized mouse line. Mol Pharmacol 80:518–528. PubMed

Hazai E, Kupfer D. (2005) Interactions between CYP2C9 and CYP2C19 in reconstituted binary systems influence their catalytic activity: possible rationale for the inability of CYP2C19 to catalyze methoxychlor demethylation in human liver microsomes. Drug Metab Dispos 33:157–164. PubMed

Head BP, Patel HH, Insel PA. (2014) Interaction of membrane/lipid rafts with the cytoskeleton: impact on signaling and function: membrane/lipid rafts, mediators of cytoskeletal arrangement and cell signaling. Biochim Biophys Acta 1838:532–545. PubMed PMC

Helenius A, Simons K. (1975) Solubilization of membranes by detergents. Biochim Biophys Acta 415:29–79. PubMed

Henderson CJ, McLaughlin LA, Scheer N, Stanley LA, Wolf CR. (2015) Cytochrome b5 is a major determinant of human cytochrome P450 CYP2D6 and CYP3A4 activity in vivo. Mol Pharmacol 87:733–739. PubMed

Henderson CJ, McLaughlin LA, Wolf CR. (2013) Evidence that cytochrome b5 and cytochrome b5 reductase can act as sole electron donors to the hepatic cytochrome P450 system. Mol Pharmacol 83:1209–1217. PubMed

Hildebrandt A, Estabrook RW. (1971) Evidence for the participation of cytochrome b 5 in hepatic microsomal mixed-function oxidation reactions. Arch Biochem Biophys 143:66–79. PubMed

Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51–59. PubMed

Im SC, Waskell L. (2011) The interaction of microsomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b(5). Arch Biochem Biophys 507:144–153. PubMed PMC

Ingelman-Sundberg M, Glaumann H. (1980) Incorporation of purified components of the rabbit liver microsomal hydroxylase system into phospholipid vesicles. Biochim Biophys Acta 599:417–435. PubMed

Ingelman-Sundberg M, Hagbjörk AL, Ueng YF, Yamazaki H, Guengerich FP. (1996) High rates of substrate hydroxylation by human cytochrome P450 3A4 in reconstituted membranous vesicles: influence of membrane charge. Biochem Biophys Res Commun 221:318–322. PubMed

Isin EM, Guengerich FP. (2008) Substrate binding to cytochromes P450. Anal Bioanal Chem 392:1019–1030. PubMed PMC

Jansson I, Schenkman JB. (1987) Influence of cytochrome b5 on the stoichiometry of the different oxidative reactions catalyzed by liver microsomal cytochrome P-450. Drug Metab Dispos 15:344–348. PubMed

Jeffcoat R, Brawn PR, Safford R, James AT. (1977) Properties of rat liver microsomal stearoyl-coenzyme A desaturase. Biochem J 161:431–437. PubMed PMC

Johnson EF, Connick JP, Reed JR, Backes WL, Desai MC, Xu L, Estrada DF, Laurence JS, Scott EE. (2014) Correlating structure and function of drug-metabolizing enzymes: progress and ongoing challenges. Drug Metab Dispos 42:9–22. PubMed PMC

Johnson EF, Stout CD. (2013) Structural diversity of eukaryotic membrane cytochrome p450s. J Biol Chem 288:17082–17090. PubMed PMC

Kelley RW, Cheng D, Backes WL. (2006) Heteromeric complex formation between CYP2E1 and CYP1A2: evidence for the involvement of electrostatic interactions. Biochemistry 45:15807–15816. PubMed PMC

Kurian JR, Longlais BJ, Trepanier LA. (2007) Discovery and characterization of a cytochrome b5 variant in humans with impaired hydroxylamine reduction capacity. Pharmacogenet Genomics 17:597–603. PubMed

London E, Brown DA. (2000) Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim Biophys Acta 1508:182–195. PubMed

Lúcio M, Lima JLFC, Reis S. (2010) Drug-membrane interactions: significance for medicinal chemistry. Curr Med Chem 17:1795–1809. PubMed

McKenna JA, Sacco J, Son TT, Trepanier LA, Callan MB, Harvey JW, Arndt JW. (2014) Congenital methemoglobinemia in a dog with a promoter deletion and a nonsynonymous coding variant in the gene encoding cytochrome b₅. J Vet Intern Med 28:1626–1631. PubMed PMC

McLaughlin LA, Ronseaux S, Finn RD, Henderson CJ, Roland Wolf C. (2010) Deletion of microsomal cytochrome b5 profoundly affects hepatic and extrahepatic drug metabolism. Mol Pharmacol 78:269–278. PubMed

Naffin-Olivos JL, Auchus RJ. (2006) Human cytochrome b5 requires residues E48 and E49 to stimulate the 17,20-lyase activity of cytochrome P450c17. Biochemistry 45:755–762. PubMed

Nagar S, Korzekwa K. (2012) Commentary: nonspecific protein binding versus membrane partitioning: it is not just semantics. Drug Metab Dispos 40:1649–1652. PubMed

Nakamura Y, Gang HX, Suzuki T, Sasano H, Rainey WE. (2009) Adrenal changes associated with adrenarche. Rev Endocr Metab Disord 10:19–26. PubMed PMC

Omura T, Sato R. (1962) A new cytochrome in liver microsomes. J Biol Chem 237:1375–1376. PubMed

Omura T, Sato R, Cooper DY, Rosenthal O, Estabrook RW. (1965) Function of cytochrome P-450 of microsomes. Fed Proc 24:1181–1189. PubMed

Ortiz de Montellano PR (2015) Cytochrome P450: Structure, Mechanism, and Biochemistry. Springer International Publishing, Switzerland.

Otyepka M, Skopalík J, Anzenbacherová E, Anzenbacher P. (2007) What common structural features and variations of mammalian P450s are known to date? Biochim Biophys Acta 1770:376–389. PubMed

Ovesný M, Křížek P, Borkovec J, Svindrych Z, Hagen GM. (2014) ThunderSTORM: a comprehensive ImageJ plug-in for PALM and STORM data analysis and super-resolution imaging. Bioinformatics 30:2389–2390. PubMed PMC

Owen DM, Rentero C, Rossy J, Magenau A, Williamson D, Rodriguez M, Gaus K. (2010) PALM imaging and cluster analysis of protein heterogeneity at the cell surface. J Biophotonics 3:446–454. PubMed

Pallan PS, Nagy LD, Lei L, Gonzalez E, Kramlinger VM, Azumaya CM, Wawrzak Z, Waterman MR, Guengerich FP, Egli M. (2015) Structural and kinetic basis of steroid 17α,20-lyase activity in teleost fish cytochrome P450 17A1 and its absence in cytochrome P450 17A2. J Biol Chem 290:3248–3268. PubMed PMC

Paloncýová M, Berka K, Otyepka M. (2013) Molecular insight into affinities of drugs and their metabolites to lipid bilayers. J Phys Chem B 117:2403–2410. PubMed

Paloncýová M, DeVane R, Murch B, Berka K, Otyepka M. (2014) Amphiphilic drug-like molecules accumulate in a membrane below the head group region. J Phys Chem B 118:1030–1039. PubMed

Park JW, Reed JR, Brignac-Huber LM, Backes WL. (2014) Cytochrome P450 system proteins reside in different regions of the endoplasmic reticulum. Biochem J 464:241–249. PubMed PMC

Park JW, Reed JR, Backes WL. (2015) The Localization of Cytochrome P450s CYP1A1 and CYP1A2 into Different Lipid Microdomains is Governed by their NH2-terminal and Internal Protein Regions. J Biol Chem 290:29449–29460. PubMed PMC

Peterson JA, Ebel RE, O’Keeffe DH, Matsubara T, Estabrook RW. (1976) Temperature dependence of cytochrome P-450 reduction. A model for NADPH-cytochrome P-450 reductase:cytochrome P-450 interaction. J Biol Chem 251:4010–4016. PubMed

Petrek M, Kosinová P, Koca J, Otyepka M. (2007) MOLE: a Voronoi diagram-based explorer of molecular channels, pores, and tunnels. Structure 15:1357–1363. PubMed

Petrek M, Otyepka M, Banás P, Kosinová P, Koca J, Damborský J. (2006) CAVER: a new tool to explore routes from protein clefts, pockets and cavities. BMC Bioinformatics 7:316–324. PubMed PMC

Pike LJ. (2009) The challenge of lipid rafts. J Lipid Res 50 (Suppl):S323–S328. PubMed PMC

Pochapsky TC, Kazanis S, Dang M. (2010) Conformational plasticity and structure/function relationships in cytochromes P450. Antioxid Redox Signal 13:1273–1296. PubMed PMC

Poudel KR, Jones JP, Brozik JA. (2013) A guide to tracking single transmembrane proteins in supported lipid bilayers. Methods Mol Biol 974:233–252. PubMed

Reed JR, Backes WL. (2012) Formation of P450 · P450 complexes and their effect on P450 function. Pharmacol Ther 133:299–310. PubMed PMC

Reed JR, Eyer M, Backes WL. (2010) Functional interactions between cytochromes P450 1A2 and 2B4 require both enzymes to reside in the same phospholipid vesicle: evidence for physical complex formation. J Biol Chem 285:8942–8952. PubMed PMC

Reed JR, Kelley RW, Backes WL. (2006) An evaluation of methods for the reconstitution of cytochromes P450 and NADPH P450 reductase into lipid vesicles. Drug Metab Dispos 34:660–666. PubMed PMC

Rendic SP, Guengerich FP. (2015) Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Chemicals. Chem Res Toxicol 28:38–42. PubMed PMC

Rock D, Rock D, Jones JP. (2001) Inexpensive purification of P450 reductase and other proteins using 2′,5′-adenosine diphosphate agarose affinity columns. Protein Expr Purif 22:82–83. PubMed

Sansen S, Yano JK, Reynald RL, Schoch GA, Griffin KJ, Stout CD, Johnson EF. (2007) Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2. J Biol Chem 282:14348–14355. PubMed

Scheer N, Kapelyukh Y, McEwan J, Beuger V, Stanley LA, Rode A, Wolf CR. (2012) Modeling human cytochrome P450 2D6 metabolism and drug-drug interaction by a novel panel of knockout and humanized mouse lines. Mol Pharmacol 81:63–72. PubMed

Seddon AM, Casey D, Law RV, Gee A, Templer RH, Ces O. (2009) Drug interactions with lipid membranes. Chem Soc Rev 38:2509–2519. PubMed

Sgrignani J, Magistrato A. (2012) Influence of the membrane lipophilic environment on the structure and on the substrate access/egress routes of the human aromatase enzyme: a computational study. J Chem Inf Model 52:1595–1606. PubMed

Shimoji M, Yin H, Higgins L, Jones JP. (1998) Design of a novel P450: a functional bacterial-human cytochrome P450 chimera. Biochemistry 37:8848–8852. PubMed

Smith D, Artursson P, Avdeef A, Di L, Ecker GF, Faller B, Houston JB, Kansy M, Kerns EH, Krämer SD, et al. (2014) Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition. Mol Pharm 11:1727–1738. PubMed

Subramanian M, Low M, Locuson CW, Tracy TS. (2009) CYP2D6-CYP2C9 protein-protein interactions and isoform-selective effects on substrate binding and catalysis. Drug Metab Dispos 37:1682–1689. PubMed PMC

Subramanian M, Tam HZhang H, Tracy TS.(2010) CYP2C9-CYP3A4 protein-protein interactions: role of the hydrophobic N terminus. Drug Metab Dispos 38:1003–1009. PubMed PMC

Tait JF, Gibson D. (1992) Phospholipid binding of annexin V: effects of calcium and membrane phosphatidylserine content. Arch Biochem Biophys 298:187–191. PubMed

Williams CH, Jr, Kamin H. (1962) Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. J Biol Chem 237:587–595. PubMed

Williams PA, Cosme J, Ward A, Angove HC, Matak Vinković D, Jhoti H. (2003) Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature 424:464–468. PubMed

Yano JK, Wester MR, Schoch GA, Griffin KJ, Stout CD, Johnson EF. (2004) The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution. J Biol Chem 279:38091–38094. PubMed

Yu X, Cojocaru V, Mustafa G, Salo-Ahen OMH, Lepesheva GI, Wade RC. (2015) Dynamics of CYP51: implications for function and inhibitor design. J Mol Recognit 28:59–73. PubMed PMC

Zanger UM, Schwab M. (2013) Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138:103–141. PubMed

Zhang H, Hamdane D, Im SC, Waskell L. (2008) Cytochrome b5 inhibits electron transfer from NADPH-cytochrome P450 reductase to ferric cytochrome P450 2B4. J Biol Chem 283:5217–5225. PubMed

Zhang H, Im SC, Waskell L. (2007) Cytochrome b5 increases the rate of product formation by cytochrome P450 2B4 and competes with cytochrome P450 reductase for a binding site on cytochrome P450 2B4. J Biol Chem 282:29766–29776. PubMed

Zhao C, Gao Q, Roberts AG, Shaffer SA, Doneanu CE, Xue S, Goodlett DR, Nelson SD, Atkins WM. (2012) Cross-linking mass spectrometry and mutagenesis confirm the functional importance of surface interactions between CYP3A4 and holo/apo cytochrome b(5). Biochemistry 51:9488–9500. PubMed PMC